SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMolten Ventures Regulatory News (MVCT)

Share Price Information for Molten Ventures (MVCT)

Share Price is delayed by 15 minutes
Get Live Data
37.80    0.00 (0.00%)
Bid:
36.80
Ask:
38.80
Spread: 2.00 (5.435%)
Market Cap: £119.60m
MVCT Live PriceLast checked at - London Stock Exchange

Intraday Molten Ventures Share Chart

Correction: Form 8.3 - MOLTEN VENTURES PLC

4 Dec 2023 16:39

Correction: Form 8.3 - MOLTEN VENTURES PLC

8.3

AMENDMENT OF SECTIONS 2b & 3aPUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:Rathbones Group Plc
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. 
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeMOLTEN VENTURES PLC
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: 
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure28/11/2023
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”No

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:1p ordinary shares
 InterestsShort positions
 Number%Number%
(1) Relevant securities owned and/or controlled:1,602,3131.04%  
(2) Cash-settled derivatives:    
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:    
TOTAL:1,602,3131.04%  

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:1p ordinary shares
Details, including nature of the rights concerned and relevant percentages:Allocation in placing of 691,110 shares as a placing of 270pThis placing is conditional on shareholders approving the issue of the new ordinary shares on 14 Dec 2023.

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/saleNumber of securitiesPrice per unit
    
    
    
    

(b) Cash-settled derivative transactions

Class of relevant securityProduct descriptione.g. CFDNature of dealinge.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
     

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitTypee.g. American, European etc.Expiry dateOption money paid/ received per unit
        

(ii) Exercise

Class of relevant securityProduct descriptione.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit
     

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealinge.g. subscription, conversionDetailsPrice per unit (if applicable)
    
    
    
    

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:(i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:If there are no such agreements, arrangements or understandings, state “none”
None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?No

Date of disclosure:29/11/2023
Contact name:Jessica Glasson – Compliance Department
Telephone number:+44 (0)151 243 7254

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at.

12
Date   Source Headline
1st May 202610:08 amRNSTotal Voting Rights
24th Apr 20267:00 amRNSIssue of Equity
17th Apr 202612:16 pmRNSIssue of Equity
7th Apr 20264:16 pmRNSDirector/PDMR Shareholding
7th Apr 20261:22 pmRNSIssue of Equity
19th Mar 202612:05 pmRNSDividend Declaration
24th Feb 20267:00 amRNSOffer for Subscription - Update
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
15th Dec 20257:00 amRNSTransaction in Own Shares
2nd Dec 20257:00 amRNSHalf-year Financial Report
7th Oct 202511:31 amRNSPublication of a Prospectus
1st Oct 202510:31 amRNSTotal Voting Rights
30th Sep 20257:00 amRNSIssue of Equity under DRIS
17th Sep 20252:45 pmRNSResult of AGM
19th Jun 20257:00 amRNSFinal Results
1st May 20259:25 amRNSTotal Voting Rights
30th Apr 20257:00 amRNSTransaction in Own Shares
25th Apr 20257:00 amRNSIssue of Equity
16th Apr 20254:40 pmRNSDirector/PDMR Shareholding
16th Apr 20254:39 pmRNSDirector/PDMR Shareholding
16th Apr 202512:37 pmRNSIssue of Equity
15th Apr 20257:00 amRNSDirector/PDMR Shareholding
4th Apr 20257:00 amRNSIssue of Equity
1st Apr 20252:33 pmRNSDirectorate Change
25th Mar 20258:48 amRNSOffer for Subscription – Update
24th Mar 20252:42 pmRNSDirector Declaration
20th Mar 20254:48 pmRNSDividend Declaration
13th Dec 202412:08 pmRNSHalf-year Report updated
12th Dec 20247:00 amRNSHalf-year Report
11th Oct 202412:20 pmRNSOffer for Subscription
1st Oct 20249:43 amRNSTotal Voting Rights
26th Sep 20241:03 pmRNSIssue of Equity
9th Sep 202411:49 amRNSIntention to launch a fundraising offer
4th Sep 20243:33 pmRNSResult of AGM
2nd Sep 202410:05 amRNSTotal Voting Rights
16th Aug 20248:15 amRNSIssue of Equity
1st Aug 202411:12 amRNSOffer for Subscription - Update
30th Jul 202410:16 amRNSAnnual Financial Report - NSM upload
29th Jul 20247:00 amRNSFinal Results
18th Jun 20242:44 pmRNSOffer Update
1st May 20244:11 pmRNSPortfolio Update
1st May 20249:36 amRNSTotal Voting Rights
24th Apr 20243:31 pmRNSIssue of Equity
15th Apr 20246:04 pmRNSTransaction in Own Shares
23rd Jan 202412:34 pmGNWDirectorate change
29th Dec 202310:03 amGNWForm 8.3 - [MOLTEN VENTURES PLC - 28 12 2023] - (CGAML)
14th Dec 202312:35 pmGNWHalf-year report
4th Dec 20234:39 pmGNWCorrection: Form 8.3 - MOLTEN VENTURES PLC
29th Nov 20232:05 pmGNWForm 8.3 - MOLTEN VENTURES PLC
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.